Standout Papers
Immediate Impact
7 by Nobel laureates 30 from Science/Nature 68 standout
Citing Papers
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
2023 Standout
What is cancer metabolism?
2023 Standout
Works of Daniel Rohle being referenced
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
2015
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
2012 StandoutNature
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Rohle | 1005 | 804 | 173 | 830 | 5 | 1.6k | |
| Christopher R. Edwards | 1235 | 577 | 152 | 692 | 7 | 1.7k | |
| Andrew Kaufman | 1164 | 815 | 216 | 753 | 10 | 1.9k | |
| Dan Rohle | 983 | 518 | 149 | 669 | 3 | 1.4k | |
| Roel G.W. Verhaak | 796 | 567 | 213 | 636 | 12 | 1.4k | |
| Olivier Keunen | 741 | 533 | 246 | 728 | 23 | 1.4k | |
| Timothy A. Chan | 1388 | 935 | 352 | 842 | 11 | 2.1k | |
| Sung‐Suk Chae | 1483 | 240 | 433 | 707 | 17 | 2.2k | |
| Marcela C. Assanah | 1118 | 403 | 388 | 642 | 11 | 1.7k | |
| Jeremy Travins | 925 | 340 | 189 | 627 | 21 | 1.4k | |
| Regina Fillbrandt | 803 | 494 | 292 | 439 | 14 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...